Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

7.9%

10 terminated/withdrawn out of 127 trials

Success Rate

85.5%

-1.0% vs industry average

Late-Stage Pipeline

7%

9 trials in Phase 3/4

Results Transparency

32%

19 of 59 completed trials have results

Key Signals

28 recruiting19 with results6 terminated4 withdrawn

Enrollment Performance

Analytics

N/A
41(54.7%)
Phase 2
11(14.7%)
Phase 1
10(13.3%)
Phase 4
7(9.3%)
Early Phase 1
4(5.3%)
Phase 3
2(2.7%)
75Total
N/A(41)
Phase 2(11)
Phase 1(10)
Phase 4(7)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (127)

Showing 20 of 127 trials
NCT02137005Active Not Recruiting

Cerebral Palsy Adult Transition Longitudinal Study

Role: collaborator

NCT04924322Phase 2Recruiting

Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies

Role: collaborator

NCT02771496Recruiting

Osteochondritis Dissecans of Knee Prospective Cohort

Role: collaborator

NCT04731272Phase 2Recruiting

GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance

Role: collaborator

NCT06191640Recruiting

Sinus Disease in Young Children With Cystic Fibrosis

Role: collaborator

NCT04211935Not ApplicableActive Not Recruiting

Identification of Best Postoperative Analgesia Method Following a Minimally Invasive Repair of Pectus Excavatum

Role: collaborator

NCT04612764Active Not Recruiting

Liver Disease in Urea Cycle Disorders

Role: collaborator

NCT07549646Phase 2Active Not Recruiting

24VA021; VATCH Trametinib for Ras/MAPK Pathway VAs

Role: collaborator

NCT05233397Phase 2Recruiting

ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma

Role: collaborator

NCT07543822Phase 2Active Not Recruiting

24VA022; VATCH Alpelisib for TIE2/PIK3CA Pathway VAs

Role: collaborator

NCT02774421Phase 1Active Not Recruiting

Pilot Study of the Effect of Trastuzumab and GM-CSF on Children With Recurrent Ependymoma

Role: collaborator

NCT04544592Phase 1Recruiting

UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL

Role: collaborator

NCT04113434Completed

Linking Endotypes and Outcomes in Pediatric Acute Respiratory Distress Syndrome

Role: collaborator

NCT06620289Enrolling By Invitation

Impact of Dental Desensitization Facilitated by a Child Life Specialist Distress and Cooperation

Role: lead

NCT07187245Not ApplicableRecruiting

Feasibility of the Reality PAWS Program for Children in Isolation

Role: lead

NCT05286788Phase 2Recruiting

MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma

Role: collaborator

NCT06162494Phase 4Enrolling By Invitation

Recombinant Zoster Vaccine in Young Adult Solid Organ Transplant Recipients

Role: collaborator

NCT04128995Phase 4Active Not Recruiting

Surgical or Medical Treatment

Role: collaborator

NCT02298348Phase 1Active Not Recruiting

Sorafenib and Cyclophosphamide/Topotecan in Patients With Relapsed and Refractory Neuroblastoma

Role: collaborator

NCT04629014Recruiting

Prospective Multisite Study of Quality of Life in Pediatric Intestinal Failure

Role: collaborator